nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—Zidovudine—acquired immunodeficiency syndrome	0.148	0.5	CrCtD
Trifluridine—Stavudine—acquired immunodeficiency syndrome	0.148	0.5	CrCtD
Trifluridine—TK1—Zidovudine—acquired immunodeficiency syndrome	0.127	0.786	CbGbCtD
Trifluridine—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.0706	0.21	CiPCiCtD
Trifluridine—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.0706	0.21	CiPCiCtD
Trifluridine—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.0706	0.21	CiPCiCtD
Trifluridine—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.0706	0.21	CiPCiCtD
Trifluridine—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.0535	0.159	CiPCiCtD
Trifluridine—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.0276	0.146	CrCrCtD
Trifluridine—Stavudine—Zidovudine—acquired immunodeficiency syndrome	0.0276	0.146	CrCrCtD
Trifluridine—Idoxuridine—Stavudine—acquired immunodeficiency syndrome	0.019	0.1	CrCrCtD
Trifluridine—Telbivudine—Zidovudine—acquired immunodeficiency syndrome	0.019	0.1	CrCrCtD
Trifluridine—Telbivudine—Stavudine—acquired immunodeficiency syndrome	0.019	0.1	CrCrCtD
Trifluridine—Idoxuridine—Zidovudine—acquired immunodeficiency syndrome	0.019	0.1	CrCrCtD
Trifluridine—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.0173	0.0912	CrCrCtD
Trifluridine—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.0173	0.0912	CrCrCtD
Trifluridine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.0157	0.0831	CrCrCtD
Trifluridine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0141	0.087	CbGbCtD
Trifluridine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0107	0.0659	CbGbCtD
Trifluridine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.00786	0.0416	CrCrCtD
Trifluridine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00561	0.0346	CbGbCtD
Trifluridine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00434	0.0268	CbGbCtD
Trifluridine—TYMP—endothelium—acquired immunodeficiency syndrome	0.000927	0.0708	CbGeAlD
Trifluridine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.000835	0.934	CrCbGaD
Trifluridine—TYMP—blood plasma—acquired immunodeficiency syndrome	0.000823	0.0629	CbGeAlD
Trifluridine—TK1—skin of body—acquired immunodeficiency syndrome	0.000742	0.0567	CbGeAlD
Trifluridine—TK1—lymphoid tissue—acquired immunodeficiency syndrome	0.000601	0.0459	CbGeAlD
Trifluridine—TK1—digestive system—acquired immunodeficiency syndrome	0.000594	0.0453	CbGeAlD
Trifluridine—Hyperaemia—Indinavir—acquired immunodeficiency syndrome	0.000584	0.187	CcSEcCtD
Trifluridine—TK1—blood—acquired immunodeficiency syndrome	0.000566	0.0432	CbGeAlD
Trifluridine—TK1—bone marrow—acquired immunodeficiency syndrome	0.000547	0.0418	CbGeAlD
Trifluridine—TK1—vagina—acquired immunodeficiency syndrome	0.000524	0.04	CbGeAlD
Trifluridine—TK1—lung—acquired immunodeficiency syndrome	0.000496	0.0379	CbGeAlD
Trifluridine—TK1—nervous system—acquired immunodeficiency syndrome	0.000459	0.0351	CbGeAlD
Trifluridine—TK1—central nervous system—acquired immunodeficiency syndrome	0.000442	0.0338	CbGeAlD
Trifluridine—TK1—brain—acquired immunodeficiency syndrome	0.000351	0.0268	CbGeAlD
Trifluridine—TYMS—skin of body—acquired immunodeficiency syndrome	0.00034	0.0259	CbGeAlD
Trifluridine—TK1—lymph node—acquired immunodeficiency syndrome	0.000339	0.0259	CbGeAlD
Trifluridine—TYMP—lymphoid tissue—acquired immunodeficiency syndrome	0.00032	0.0245	CbGeAlD
Trifluridine—TYMP—digestive system—acquired immunodeficiency syndrome	0.000317	0.0242	CbGeAlD
Trifluridine—TYMP—blood—acquired immunodeficiency syndrome	0.000302	0.023	CbGeAlD
Trifluridine—TYMP—bone marrow—acquired immunodeficiency syndrome	0.000292	0.0223	CbGeAlD
Trifluridine—TYMP—spinal cord—acquired immunodeficiency syndrome	0.000291	0.0222	CbGeAlD
Trifluridine—TYMP—vagina—acquired immunodeficiency syndrome	0.00028	0.0213	CbGeAlD
Trifluridine—TYMS—lymphoid tissue—acquired immunodeficiency syndrome	0.000275	0.021	CbGeAlD
Trifluridine—TYMS—digestive system—acquired immunodeficiency syndrome	0.000272	0.0207	CbGeAlD
Trifluridine—TYMP—lung—acquired immunodeficiency syndrome	0.000264	0.0202	CbGeAlD
Trifluridine—TYMS—blood—acquired immunodeficiency syndrome	0.000259	0.0198	CbGeAlD
Trifluridine—TYMS—bone marrow—acquired immunodeficiency syndrome	0.00025	0.0191	CbGeAlD
Trifluridine—TYMP—nervous system—acquired immunodeficiency syndrome	0.000245	0.0187	CbGeAlD
Trifluridine—TYMS—vagina—acquired immunodeficiency syndrome	0.00024	0.0183	CbGeAlD
Trifluridine—TYMP—central nervous system—acquired immunodeficiency syndrome	0.000236	0.018	CbGeAlD
Trifluridine—Dry eye—Didanosine—acquired immunodeficiency syndrome	0.000232	0.0743	CcSEcCtD
Trifluridine—TYMS—lung—acquired immunodeficiency syndrome	0.000227	0.0173	CbGeAlD
Trifluridine—TYMS—nervous system—acquired immunodeficiency syndrome	0.00021	0.016	CbGeAlD
Trifluridine—TYMS—central nervous system—acquired immunodeficiency syndrome	0.000202	0.0154	CbGeAlD
Trifluridine—TYMP—brain—acquired immunodeficiency syndrome	0.000187	0.0143	CbGeAlD
Trifluridine—TYMP—lymph node—acquired immunodeficiency syndrome	0.000181	0.0138	CbGeAlD
Trifluridine—SLC22A6—brain—acquired immunodeficiency syndrome	0.00018	0.0138	CbGeAlD
Trifluridine—TYMS—brain—acquired immunodeficiency syndrome	0.000161	0.0123	CbGeAlD
Trifluridine—TYMS—lymph node—acquired immunodeficiency syndrome	0.000155	0.0118	CbGeAlD
Trifluridine—Dry eye—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.0472	CcSEcCtD
Trifluridine—Dry eye—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.042	CcSEcCtD
Trifluridine—Pain—Didanosine—acquired immunodeficiency syndrome	7.66e-05	0.0246	CcSEcCtD
Trifluridine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.0233	CcSEcCtD
Trifluridine—Pain—Nevirapine—acquired immunodeficiency syndrome	6.89e-05	0.0221	CcSEcCtD
Trifluridine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.022	CcSEcCtD
Trifluridine—Pain—Nelfinavir—acquired immunodeficiency syndrome	6.67e-05	0.0214	CcSEcCtD
Trifluridine—Pain—Stavudine—acquired immunodeficiency syndrome	6.65e-05	0.0213	CcSEcCtD
Trifluridine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	6.6e-05	0.0212	CcSEcCtD
Trifluridine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.021	CcSEcCtD
Trifluridine—Pain—Abacavir—acquired immunodeficiency syndrome	6.55e-05	0.021	CcSEcCtD
Trifluridine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.0195	CcSEcCtD
Trifluridine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	5.94e-05	0.019	CcSEcCtD
Trifluridine—Zidovudine—ALB—acquired immunodeficiency syndrome	5.89e-05	0.0659	CrCbGaD
Trifluridine—Nausea—Amprenavir—acquired immunodeficiency syndrome	5.84e-05	0.0187	CcSEcCtD
Trifluridine—Pain—Zidovudine—acquired immunodeficiency syndrome	5.78e-05	0.0185	CcSEcCtD
Trifluridine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	5.75e-05	0.0184	CcSEcCtD
Trifluridine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	5.73e-05	0.0184	CcSEcCtD
Trifluridine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	5.65e-05	0.0181	CcSEcCtD
Trifluridine—Pain—Indinavir—acquired immunodeficiency syndrome	5.38e-05	0.0172	CcSEcCtD
Trifluridine—Nausea—Didanosine—acquired immunodeficiency syndrome	5.32e-05	0.0171	CcSEcCtD
Trifluridine—Pain—Efavirenz—acquired immunodeficiency syndrome	5.08e-05	0.0163	CcSEcCtD
Trifluridine—Pain—Delavirdine—acquired immunodeficiency syndrome	4.86e-05	0.0156	CcSEcCtD
Trifluridine—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.79e-05	0.0153	CcSEcCtD
Trifluridine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.64e-05	0.0149	CcSEcCtD
Trifluridine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	4.63e-05	0.0148	CcSEcCtD
Trifluridine—Nausea—Stavudine—acquired immunodeficiency syndrome	4.62e-05	0.0148	CcSEcCtD
Trifluridine—Nausea—Abacavir—acquired immunodeficiency syndrome	4.55e-05	0.0146	CcSEcCtD
Trifluridine—Pain—Ritonavir—acquired immunodeficiency syndrome	4.5e-05	0.0144	CcSEcCtD
Trifluridine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.38e-05	0.014	CcSEcCtD
Trifluridine—Pain—Saquinavir—acquired immunodeficiency syndrome	4.33e-05	0.0139	CcSEcCtD
Trifluridine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.19e-05	0.0134	CcSEcCtD
Trifluridine—Pain—Lamivudine—acquired immunodeficiency syndrome	4.13e-05	0.0132	CcSEcCtD
Trifluridine—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.02e-05	0.0129	CcSEcCtD
Trifluridine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.87e-05	0.0124	CcSEcCtD
Trifluridine—Nausea—Indinavir—acquired immunodeficiency syndrome	3.74e-05	0.012	CcSEcCtD
Trifluridine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.0119	CcSEcCtD
Trifluridine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.0114	CcSEcCtD
Trifluridine—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.53e-05	0.0113	CcSEcCtD
Trifluridine—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.0108	CcSEcCtD
Trifluridine—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.01	CcSEcCtD
Trifluridine—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.00963	CcSEcCtD
Trifluridine—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.00919	CcSEcCtD
